Mol Cancer Ther
From Bioblast
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Journal title and website | Molecular Cancer Therapeutics |
---|
Publications
Reference | Published | View | |
---|---|---|---|
Teh 2019 Mol Cancer Ther | Teh JT, Zhu WL, Newgard CB, Casey PJ, Wang M (2019) Respiratory capacity and reserve predict cell sensitivity to mitochondria inhibitors: mechanism-based markers to identify metformin-responsive cancers. Mol Cancer Ther 18:693-705. | 2019 | PMID: 30824582 Open Access |
Schlaepfer 2014 Mol Cancer Ther | Schlaepfer IR, Rider L, Rodrigues LU, Gijón MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glodé LM, Eckel RH, Cramer SD (2014) Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol Cancer Ther 13:2361-71. | 2014 | PMID:25122071 Open Access |